Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$135.6K
10.31K shares
What this filing means
SCHOENBERG MARK plans to sell 10.31K shares of UROGEN PHARMA LTD. valued at approximately $135.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/29/2025ACC: 0001976408-25-000249
Officer· Chief Medical Officer
Since Jan 2019
10.31K
Shares to sell
$135.6K
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/31/2024
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2024 | Restricted Stock Units N/A | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.16K
Market value
$38.0K
6/9/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.15K
Market value
$97.6K
7/28/2025
Total
Units
10.31K
Value
$135.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/9/2025 | 5.16K | $38.0K | — | Completed |
| Planned — Approximate Date | ||||
7/28/2025 | 5.15K | $97.6K | NASDAQ | Planned |
| Total | 10.31K | $135.6K | ||